Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Louis Tong, Chi Chin Sun, Kyung Chul Yoon, Ruben Lim Bon Siong, Vilavun Puangsricharern & Christophe Baudouin. (2021) Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review. Ocular Immunology and Inflammation 29:7-8, pages 1606-1615.
Read now
Read now
Candela Rodríguez-Pomar, Jesus Pintor, Basilio Colligris & Gonzalo Carracedo. (2017) Therapeutic inhibitors for the treatment of dry eye syndrome. Expert Opinion on Pharmacotherapy 18:17, pages 1855-1865.
Read now
Read now
Articles from other publishers (11)
Yaser Yousefpoor, Seyedeh Sara Esnaashari, Hadi Baharifar, Mohsen Mehrabi & Amir Amani. (2023) Current challenges ahead in preparation, characterization, and pharmaceutical applications of nanoemulsions. WIREs Nanomedicine and Nanobiotechnology 15:6.
Crossref
Crossref
Shiding Li, Liangbo Chen & Yao Fu. (2023) Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Adaeze Linda Onugwu, Chinekwu Sherridan Nwagwu, Obinna Sabastine Onugwu, Adaeze Chidiebere Echezona, Chinazom Precious Agbo, Stella Amarachi Ihim, Prosper Emeh, Petra Obioma Nnamani, Anthony Amaechi Attama & Vitaliy V. Khutoryanskiy. (2023) Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. Journal of Controlled Release 354, pages 465-488.
Crossref
Crossref
V.V. Brzheskiy. (2023) Modern possibilities of pathogenetically oriented therapy for dry eye syndrome. Vestnik oftal'mologii 139:2, pages 95.
Crossref
Crossref
Tarun Virmani, Girish Kumar, Ashwani Sharma & Kamla Pathak. 2023. Nanotechnology in Ophthalmology. Nanotechnology in Ophthalmology
23
48
.
Mehrdad Afarid, Shirin Mahmoodi & Roghayyeh Baghban. (2022) Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Louis Tong, Li Lim, Donald Tan, Wee Jin Heng, Jimmy Lim, Cordelia Chan, Anshu Arundhati & Anna Tan. (2021) Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework. Asia-Pacific Journal of Ophthalmology 10:6, pages 530-541.
Crossref
Crossref
Rujun Jin, Ying Li, Lan Li, Jonghwa Kim, Hyeon Yoon & Kyung Yoon. (2021) Comparative analysis of 0.1% cyclosporin A cationic emulsion and 0.05% cyclosporin A emulsion in murine dry eye cases with different severities. Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Rashmi Deshmukh, Darren Shu Jeng Ting, Ahmad Elsahn, Imran Mohammed, Dalia G Said & Harminder Singh Dua. (2021) Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. British Journal of Ophthalmology, pages bjophthalmol-2020-317907.
Crossref
Crossref
Srividya Gorantla, Vamshi Krishna Rapalli, Tejashree Waghule, Prem Prakash Singh, Sunil Kumar Dubey, Ranendra N. SahaGautam Singhvi. (2020) Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Advances 10:46, pages 27835-27855.
Crossref
Crossref
Roseline Mazet, Josias B. G. Yaméogo, Denis Wouessidjewe, Luc Choisnard & Annabelle Gèze. (2020) Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation. Pharmaceutics 12:6, pages 570.
Crossref
Crossref